← 返回

长链非编码 RNA 的免疫调节特性及其作为癌症治疗靶点的潜在应用概述

英文原题:An Overview of the Immune Modulatory Properties of Long Non-Coding RNAs and Their Potential Use as Therapeutic Targets in Cancer.

查看英文原题

An Overview of the Immune Modulatory Properties of Long Non-Coding RNAs and Their Potential Use as Therapeutic Targets in Cancer.

PubMed 2023/11/11(内容时间) Noncoding RNA Q1 · IF 4.2(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

长链非编码 RNA(lncRNA)在调节免疫反应、免疫细胞分化、激活和炎症过程中发挥关键作用。在癌症中,它们因能够调节免疫检查点分子和免疫相关因子而日益成为潜在的治疗靶点,这为增强抗肿瘤免疫反应提供了途径。在此,我们探讨 lncRNA 介导免疫调节的机制见解,强调其对免疫力的影响。此外,我们讨论其增强癌症免疫治疗的潜力,提高免疫检查点抑制剂和过继性 T 细胞疗法的有效性。作为治疗靶点的 lncRNA 有望彻底改变癌症治疗,激发该领域的进一步研究,具有重大的临床意义。

展开英文摘要原文

Long non-coding RNAs (lncRNAs) play pivotal roles in regulating immune responses, immune cell differentiation, activation, and inflammatory processes. In cancer, they are gaining prominence as potential therapeutic targets due to their ability to regulate immune checkpoint molecules and immune-related factors, suggesting avenues for bolstering anti-tumor immune responses.

Here, we explore the mechanistic insights into lncRNA-mediated immune modulation, highlighting their impact on immunity.

Additionally, we discuss their potential to enhance cancer immunotherapy, augmenting the effectiveness of immune checkpoint inhibitors and adoptive T cell therapies. LncRNAs as therapeutic targets hold the promise of revolutionizing cancer treatments, inspiring further research in this field with substantial clinical implications.

论文信息

作者
Martinez-Castillo M、M Elsayed A、López-Berestein G、Amero P、Rodríguez-Aguayo C
单位
Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA.United States
文献类型
综述
期刊
Non-coding RNA2023 Nov 11
原文标识
PubMed 37987366 · DOI 10.3390/ncrna9060070